In a recent Viewpoint on missing heritability (Missing heritability and strategies for finding the underlying causes of complex disease. Nature Rev. Genet. 11, 446–450 (2010))1, several commentators mentioned the expected importance of rare variants. Except for copy number polymorphisms (CNPs), contemporary technologies do not enable the systematic identification of rare variants that, given moderate effect size, could contribute significantly to missing heritability2. However strategies to identify such sequence changes will soon become available3.
In this context we wish to highlight an emerging mechanism contributing to the introduction of new disease alleles into the population, which we term paternal age effect (PAE) mutation. The best-characterized PAE mutations encode mutant proteins with gain-of-function properties and share other distinctive features: near-exclusive paternal origin, high apparent germline mutation rate (up to 1,000-fold above background), and elevated paternal age (by 2–5 years, compared to the population average). Well-documented examples are in the fibroblast growth factor receptor 2 (FGFR2), FGFR3, RET, protein tyrosine phosphatase, non-receptor type 11 (PTPN11) and HRAS genes, heterozygous substitutions of which cause congenital skeletal disorders, sometimes with additional predisposition to cancer4.
Recent evidence, based on quantification of mutation levels in sperm4,5 and testes6, indicates that the spermatogonial (pre-meiotic) cells in which PAE mutations originally arose are positively selected and expand clonally (Fig. 1). This clonal growth, which is likely to take place in the testes of all men, leads to the relative enrichment of mutant sperm over time — accounting for the distinctive paternal age effect of these mutations — and in extreme cases, to the formation of testicular tumours4.
All well-established PAE mutations activate one pathway, involving growth factor receptor–RAS signalling4,7. This is likely to reflect a crucial role of this pathway in controlling the fate choice (self-renewal versus differentiation to produce mature sperm) of spermatogonial cells; additional pathways involved in the proliferation and survival of spermatogonia might also be vulnerable to such 'selfish' mutations. Given the importance of RAS in many contexts (for example, neurogenesis, organ homeostasis and tumorigenesis) the consequences of similar but more weakly acting spermatogonial mutations (which might be CNPs, regulatory mutations or coding substitutions) could affect a wide range of phenotypes, including neurocognitive disorders and cancer predisposition7,8,9. Intriguingly, paternal age effects have been reported in several of these disorders10,11,12. Although de novo mutations do not themselves contribute to heritability, they will do so if the phenotypic effect is mild enough to permit transmission of the new mutation to subsequent generations.
How might the overall contribution of PAE mutations to disease be quantified? Direct measurements4,5,6 in normal sperm and testes are laborious, and segregation of normal and mutant alleles in sperm of heterozygotes for PAE mutations is not expected to deviate from 50:50. Recently, the first direct study of new mutations in the human germ line, obtained by whole-genome sequencing of a family quartet, estimated ∼70 new mutations per diploid genome13. Impressive as this work is, it did not mention the age of the parents at the birth of each child, nor was the parental origin of each mutation (which could be established using physically linked SNPs)14 analysed. As further studies are undertaken, we urge investigators to include this information, so that an overall picture of the contribution of PAE mutations to disease burden can be established.
Eichler, E. E. et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nature Rev. Genet. 11, 446–450 (2010).
Bodmer, W. & Bonilla, C. Common and rare variants in multifactorial susceptibility to common diseases. Nature Genet. 40, 695–701 (2008).
Cirulli, E. T. & Goldstein D. B. Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nature Rev. Genet. 11, 415–425 (2010).
Goriely, A. et al. Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nature Genet. 41, 1247–1252 (2009).
Goriely, A., McVean, G. A. T., Röjmyr, M., Ingemarsson, B. & Wilkie, A. O. M. Evidence for selective advantage of pathogenic FGFR2 mutations in the male germ line. Science 301, 643–646 (2003).
Qin, J. et al. The molecular anatomy of spontaneous germline mutations in human testes. PLoS Biol. 5, e224 (2007).
Schubbert, S., Shannon, K. & Bollag, G. Hyperactive Ras in developmental disorders and cancer. Nature Rev. Cancer 7, 295–308 (2007).
Samuels, I. S., Saitta, S. C. & Landreth, G. E. MAP'ing CNS development and cognition: an ERKsome process. Neuron 61, 160–167 (2009).
Pinto, D. et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 9 Jun 2010 (doi:10.1038/nature0 9146).
Malaspina, D. Paternal factors and schizophrenia risk: de novo mutations and imprinting. Schizophr. Bull. 3, 379–393 (2001).
Grether, J. K., Anderson, M. C., Croen, L. A., Smith, D. & Windham, G. C. Risk of autism and increasing maternal and paternal age in a large North American population. Am. J. Epidemiol. 170, 1118–1126 (2009).
Weiss-Salz, I. et al. Ethnic ancestry and increased paternal age are risk factors for breast cancer before the age of 40 years. Eur. J. Cancer Prevent. 16, 549–554 (2007).
Roach, J. C. et al. Analysis of genetic inheritance in a family quartet by whole-genome sequencing. Science 328, 636–639 (2010).
Moloney, D. M. et al. Exclusive paternal origin of new mutations in Apert syndrome. Nature Genet. 13, 48–53 (1996).
Crow, J. F. Age and sex effects on human mutation rates: an old problem with new complexities. J. Radiat. Res. 47, B75–B82 (2006).
About this article
Cite this article
Goriely, A., Wilkie, A. Missing heritability: paternal age effect mutations and selfish spermatogonia. Nat Rev Genet 11, 589 (2010). https://doi.org/10.1038/nrg2809-c1
Fertility and Sterility (2019)
Molecular Genetics & Genomic Medicine (2019)
Clinical Chemistry (2019)
Human Reproduction Update (2018)
Advanced paternal age effects in neurodevelopmental disorders—review of potential underlying mechanisms
Translational Psychiatry (2017)